Strategies of pluripotent stem cell-based therapy for retinal degeneration: update and challenges

被引：30
|
作者：
Maeda, Tadao [1 ,2 ,3 ]
Mandai, Michiko [1 ,2 ,3 ]
Sugita, Sunao [1 ,2 ,3 ,4 ]
Kime, Cody [3 ,5 ]
Takahashi, Masayo [1 ,2 ,3 ,4 ]
机构：
[1] Kobe City Eye Hosp, Res Ctr, Kobe, Hyogo 6500047, Japan
[2] Kobe City Eye Hosp, Dept Ophthalmol, Kobe, Hyogo 6500047, Japan
[3] RIKEN Ctr Biosyst Dynam Res, Lab Retinal Regenerat, Kobe, Hyogo 6500047, Japan
[4] Vis Care Inc, Kobe, Hyogo 6500047, Japan
[5] Trans Ova Genet, Sioux Ctr, IA USA
来源：
TRENDS IN MOLECULAR MEDICINE | 2022年 / 28卷 / 05期
关键词：
PIGMENT EPITHELIAL-CELLS; IMMUNE PRIVILEGE; IPS CELLS; TRANSCRIPTION FACTORS; MOUSE FIBROBLASTS; DIRECT CONVERSION; VISUAL FUNCTION; NEURAL RETINA; TRANSPLANTATION; SHEETS;
D O I：
10.1016/j.molmed.2022.03.001
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Stem cell-based therapy for retinal degeneration is transitioning from the research stage to the clinical stage and is being developed as a treatment across the globe. In clinical studies on induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) transplantation, the safety of the technique has started to clarify, and clinical study on further advances such as the long desired transplantation of iPSC-derived retina to treat retinitis pigmentosa (RP) has begun. Ophthalmologists are now working closely with basic researchers to incorporate new technology areas with a synergy that is anticipated to realize the practical application of stem cell-based therapy for retinal degeneration.
引用
收藏
页码：388 / 404
页数：17
相关论文
共 50 条
  • [31] An Update on Retinal Stem Cell Therapy
    Chao J.R.
    Lamba D.A.
    Current Ophthalmology Reports, 2013, 1 (3) : 113 - 121
  • [32] Cell therapy for macular degeneration—first phase I/II pluripotent stem cell-based clinical trial shows promise
    ZhiGuo Chen
    Y. Alex Zhang
    Science China Life Sciences, 2015, 58 : 119 - 120
  • [33] Stem/progenitor cell-based transplantation for retinal degeneration: a review of clinical trials
    Wang, Yiqi
    Tang, Zhimin
    Gu, Ping
    CELL DEATH & DISEASE, 2020, 11 (09)
  • [34] Stem/progenitor cell-based transplantation for retinal degeneration: a review of clinical trials
    Yiqi Wang
    Zhimin Tang
    Ping Gu
    Cell Death & Disease, 11
  • [35] Human induced pluripotent stem cell-derived retinal organoids and their potential for stem cell-based therapies for retinal degenerative diseases
    Soler, Valeria Canto
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [36] Stem Cell-Based Therapy for Asherman Syndrome: Promises and Challenges
    Gao, Yiyin
    Wu, Guijie
    Xu, Ying
    Zhao, Donghai
    Zheng, Lianwen
    CELL TRANSPLANTATION, 2021, 30
  • [37] Challenges and Prospects for Stem Cell-Based Therapy in Diabetes Mellitus
    Assady, Suheir
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2009, 11 (04): : 212 - 215
  • [38] Cell therapy for macular degeneration-first phase I/II pluripotent stem cell-based clinical trial shows promise
    Chen ZhiGuo
    Zhang, Y. Alex
    SCIENCE CHINA-LIFE SCIENCES, 2015, 58 (01) : 119 - 120
  • [39] Human artificial chromosomes for pluripotent stem cell-based tissue replacement therapy
    Sinenko, Sergey A.
    Ponomartsev, Sergey, V
    Tomilin, Alexey N.
    EXPERIMENTAL CELL RESEARCH, 2020, 389 (01)
  • [40] Stem cell therapy for retinal ganglion cell degeneration
    Cen, Ling-Ping
    Ng, Tsz Kin
    NEURAL REGENERATION RESEARCH, 2018, 13 (08) : 1352 - 1353
12345